PP
INFI

PDT Partners’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

PDT Partners’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-184,612
Closed -$2.02M – 1641
2015
Q2 		$2.02M Buy
184,612
+21,671
+13% +$278K 0.05% 422
2015
Q1 		$2.28M Buy
162,941
+99,841
+158% +$1.53M 0.06% 420
2014
Q4 		$1.07M Buy
63,100
+9,500
+18% +$138K 0.1% 230
2014
Q3 		$719K Buy
+53,600
New +$638K 0.02% 818
2013
Q3 		– Sell
-93,697
Closed -$1.52M – 1770
2013
Q2 		$1.52M Buy
+93,697
New +$2.9M 0.04% 655

Other funds holding INFI

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PDT Partners's INFI Position: Q3 2015 in Review

PDT Partners sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2015, closing a stake of 184,612 shares — an estimated $2.02M sold.

PDT Partners first reported a position in INFI in Q2 2013 and held it in 5 quarters. The position peaked at $2.28M in Q1 2015. 129 funds tracked by Wall St. Rank hold INFI as of Q3 2015.

  • PDT Partners reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
  • PDT Partners sold 184,612 Infinity Pharmaceuticals, Inc. shares in Q3 2015, an estimated $2.02M.
  • PDT Partners first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 5 quarters.
  • PDT Partners's Infinity Pharmaceuticals, Inc. position peaked at $2.28M in Q1 2015.
  • 129 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2015.

Based on PDT Partners's 13F filing for Q3 2015, filed 16 Nov 2015.